Prognostic Factors in Non-occlusive mesenteric ischemia: A pragmatic pre-operative score for the prediction of 28-day mortality.

Computed tomography Critical care Non-occlusive mesenteric ischemia Prognosis Small bowel

Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
07 2022
Historique:
received: 12 10 2021
revised: 08 02 2022
accepted: 25 03 2022
pubmed: 7 4 2022
medline: 28 6 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

The prognosis of critical ill patients with non-occlusive mesenteric ischemia (NOMI) is poor and not fully understood. We aimed to determine preoperative factors associated with 28-day mortality in NOMI. Variables associated with 28-day mortality were entered into a multivariate cox regression model and were used to compute a NOMI mortality score. 154 patients were included. The 28-day mortality rate was 56%. Multivariable analyses including variables at the time of the CT identified three variables (i.e. lactates > 7 mmoL/l, prothrombin rate <60% and kidney infarction), included in a simple score. Among the study population, the probability of 28-day mortality was 26% (11/42), 54% (26/48), 77% (23/30) and 100% (21/21) for a survival score of 0, 1, 2 and 3, respectively. A simple score combining these three variables, calculated preoperatively, was able to accurately predict 28-day mortality and might help to avoid futile laparotomies.

Sections du résumé

BACKGROUND
The prognosis of critical ill patients with non-occlusive mesenteric ischemia (NOMI) is poor and not fully understood. We aimed to determine preoperative factors associated with 28-day mortality in NOMI.
METHODS
Variables associated with 28-day mortality were entered into a multivariate cox regression model and were used to compute a NOMI mortality score.
RESULTS
154 patients were included. The 28-day mortality rate was 56%. Multivariable analyses including variables at the time of the CT identified three variables (i.e. lactates > 7 mmoL/l, prothrombin rate <60% and kidney infarction), included in a simple score. Among the study population, the probability of 28-day mortality was 26% (11/42), 54% (26/48), 77% (23/30) and 100% (21/21) for a survival score of 0, 1, 2 and 3, respectively.
CONCLUSION
A simple score combining these three variables, calculated preoperatively, was able to accurately predict 28-day mortality and might help to avoid futile laparotomies.

Identifiants

pubmed: 35382932
pii: S0002-9610(22)00226-4
doi: 10.1016/j.amjsurg.2022.03.048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-623

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Paul Calame (P)

Service de Radiologie, CHU Besançon, F- 25030, Besançon, France; EA 4662 Nanomedicine Lab, Imagery and Therapeutics, University of Franche-Comté, Besançon, France. Electronic address: p1calame@chu-besancon.fr.

Hadrien Winiszewski (H)

Service de Réanimation Médicale, CHU Besançon, F- 25030, Besançon, France.

Zaher Lakkis (Z)

Service de Chirurgie Digestive, CHU Besançon, F- 25030, Besançon, France.

Pierre Verdot (P)

Service de Radiologie, CHU Besançon, F- 25030, Besançon, France.

Sebastien Pili-Floury (S)

Service de Réanimation Chirurgicale, CHU Besançon, F- 25030, Besançon, France.

Bruno Heyd (B)

Service de Chirurgie Digestive, CHU Besançon, F- 25030, Besançon, France.

Gael Piton (G)

Service de Réanimation Médicale, CHU Besançon, F- 25030, Besançon, France.

Eric Delabrousse (E)

Service de Radiologie, CHU Besançon, F- 25030, Besançon, France; Service de Réanimation Chirurgicale, CHU Besançon, F- 25030, Besançon, France.

Alexandre Doussot (A)

Service de Chirurgie Digestive, CHU Besançon, F- 25030, Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH